This position is at the intersection of a deep learning scientist and a software engineer. In this role you'll read the latest research papers on neural networks and implement them in common frameworks, as well as in proprietary formats. You'll need to assess their correctness (such as their structure, convergence, and numerical stability) for inference and training across computational devices and frameworks. Passion for reading and understanding the latest research papers in the space is required. The work will begin with Python and pseudo-code, and you'll also be expected to deep dive into frameworks code (C).

If you know of other resources we should link to, please help other listeners by either replying to us on Twitter (#DMpodcast) or emailing us at podcast@deepmind.com. You can also use that address to send us questions or feedback on the series.

This is Pharma's AlphaGo moment when the potential for AI to radically transform the normal operating procedures and business models of the entire industry becomes tangibly obvious to the public. In the case of the AI industry, this happened in 2015, when AI company DeepMind succeeded in developing the first AI capable of beating a human Go champion in Go. This study by Insilico Medicine may be an analogous game-changing moment for Pharma. While it typically takes 2-3 years to go from initial drug discovery to preclinical validation, Insilico Medicine has done this in less than 2 months end-to-end. This is 15 times faster than Pharma companies capable of conducting the most efficient R&D processes. In a landmark study published in Nature Biotechnology on September 2, 2019, Insilico Medicine showed that they generated and validated a novel small molecule in just 46 days, and designed the drug from scratch based on specified molecular properties in just 21 days.

If not, these people call themselves The Myth Busters. Heck, they've even got a show of their own on discovery channel where they try to live up to their name, trying to bust myths like whether you can cut a jail bar by repeatedly eroding it with a dental floss. Inspired by them, we, at Paperspace, are going do something similar. The Myth we are going to tackle is whether Batch Normalization indeed solves the problem of Internal Covariate Shift. Though Batch normalization been around for a few years and has become a staple in deep architectures, it remains one of the most misunderstood concepts in deep learning. Does Batch Norm really solve internal covariate shift?

Understanding the behavior of artificial intelligence(AI) agents is one of the pivotal challenges of the next decade of AI. Interpretability or explainability are some of the terms often used to describe methods that provide insights about the behavior of AI programs. Until today, most of the interpretability techniques have focused on exploring the internal structure of deep neural networks. Recently, a group of AI researchers from the Massachusetts Institute of Technology(MIT) are exploring a radical approach that attempts to explain the behavior of AI observing them in the same we study human or animal behavior. They group the ideas in this area under the catchy name of machine behavior which promises to be one of the most exciting fields in the next few years of AI.

Project description Our society is changing. Artificial Intelligence (AI) and related technologies are playing an increasingly important role in our society. To this end Leiden University has started a new, university wide initiative to enable collaboration on the use of AI. By building on and expanding the already existing expertise of AI the project intends to advance science and improve the quality of our life. All the disciplines of the University of Leiden are involved: Archeology, Humanities, Social Sciences, Law, Public Administration, Sciences, and also the Leiden University Medical Centre (LUMC), to collaborate and appoint new staff with joint interests.

We are living in a world of constant progress on the technological ground, and looking at how computing is getting advanced day after day. We can also predict what is to come in the days ahead. The algorithm of machine learning, also called model is a mathematical expression that represents information or data in the context of any particular problem, which is often a business problem. The main aim is to go from data to insight. For instance, if an eCommerce retailer wants to anticipate sales for the next quarter for his/ her business, they might use a machine-learning algorithm to predict sales based on past sales and various other relevant & crucial data.

We fell for Recurrent neural networks (RNN), Long-short term memory (LSTM), and all their variants. Now it is time to drop them! It is the year 2014 and LSTM and RNN make a great come-back from the dead. But we were all young and unexperienced. For a few years this was the way to solve sequence learning, sequence translation (seq2seq), which also resulted in amazing results in speech to text comprehension and the raise of Siri, Cortana, Google voice assistant, Alexa.

We use a variety of machine learning models for different use cases. These include Convolutional Neural Networks for logo and icon ranking, Word Embeddings and Recurrent Neural Networks for semantics understanding, Random Forests for color generation, and Genetic Algorithms for logo generation. Different packages come with different logo files. For the basic package, you will get png files in different resolutions and colors. That sounds nice for just 9$, right?

Processed tissue slide viewing and assessment is crucial in determining the diagnosis and cancer staging. This protocol is thus instrumental in deciding the treatment therapy for a patient. Applications of deep learning and AI in the medical fields such as dermatology, radiology, ophthalmology, and pathology have shown great potential in providing great accuracy in diagnosis. Although AI promises to provide quality healthcare, the cost of slide digitization and lack of infrastructure for AI deployments remain as barriers for widespread adoption of digital pathology in clinical settings. Google recently published a paper in Nature demonstrating the prediction of metastatic breast cancer in lymph nodes using convolutional neural networks at an accuracy comparable to pathologists.